MicroVention is now Terumo Neuro

Game-changing impact™

Driving transformation through game-changing innovation

See what we do

Hemorrhagic

Terumo Neuro has a comprehensive portfolio of devices to treat or prevent hemorrhagic stroke. Our solutions for unruptured and ruptured aneurysms and neurovascular malformations are backed by robust clinical data and provide proven performance and versatility.

Ischemic

Terumo Neuro has developed an innovative portfolio of devices to treat ischemic stroke and carotid artery disease, which are blockages that limit or prevent blood flow into the brain. Our devices include aspiration catheters, stentrievers, and carotid stents.

Access

Terumo Neuro develops a full range of access products, including catheters and guidewires, that allow physicians to gain access to the treatment area. We strive to provide a wide range of innovative, high-quality access products designed to improve patient outcomes.

Products

Our cutting-edge products lead the way in the treatment and prevention of hemorrhagic and ischemic stroke.

Featured Products

Hemorrhagic

Ischemic

Access

Browse all products

Careers

We set the bar high for ourselves and it wouldn’t be possible without a collaborative work environment that values professional growth and innovation. Come work alongside us in a rewarding and relaxed environment.

Work with us

Latest Videos

World Stroke Day Video Thumbnail

Dr. Kendrick Johnson Video Highlights the Importance of Stroke Awareness

World stroke day thumbnail

World Stroke Day Patient Stories from Germany

Dianne Patient Video Thumbnail

Ischemic Stroke Patient Video

Latest News

View newsroom

Oct 29, 2024

Terumo Neuro and Tulane University School of Medicine’s Dr. Kendrick Johnson Release Educational Video Highlighting the Importance of Stroke Awareness and Equitable Healthcare in Honor of World Stroke Day 2024

In honor of World Stroke Day on October 29, 2024, Terumo Neuro has partnered with Tulane University School of Medicine and Dr. Kendrick Johnson, Assistant Professor of Neurosurgery at Tulane University School of Medicine, to release a compelling educational video focused on raising awareness about stroke education and the critical need for equitable healthcare access.

Sep 12, 2024

MicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.

Jul 23, 2024

MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms

MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms.

Upcoming Events

February 5-7, 2025 Los Angeles, CA

ISC 2025

International Stroke Conference

March 27-28, 2025 Sao Paulo, BR

LINNC Americas 2025

Live Interventional Neuroradiology, Neurology & Neurosurgery Course